Sector
PharmaceuticalsOpen
₹133.2Prev. Close
₹133.02Turnover(Lac.)
₹36Day's High
₹136.95Day's Low
₹132.4152 Week's High
₹214.9552 Week's Low
₹129.3Book Value
₹54.52Face Value
₹10Mkt Cap (₹ Cr.)
592.7P/E
0EPS
0Divi. Yield
0
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 43.45 | 32.56 | 16.28 | 10.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 193.43 | 67.93 | 55.18 | 78.08 |
Net Worth | 236.88 | 100.49 | 71.46 | 88.58 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
|---|---|---|
Gross Sales | 182.06 | 333.91 |
Excise Duty | 0 | 0 |
Net Sales | 182.06 | 333.91 |
Other Operating Income | 0 | 0 |
Other Income | 9.68 | 4.86 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Velji Gogri
Managing Director
Santosh S. Vora
Director
Shantilal Shivji Vora
Executive Director
Paresh Shashikant Shah
Independent Director
Sonal A Vira
Addtnl Non-Executive Director
Sandeep Gupta..
Company Sec. & Compli. Officer
Saloni Mehta
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Valiant Laboratories Ltd
Summary
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the C
Read More
What is the Valiant Laboratories Ltd share price today?
The Valiant Laboratories Ltd shares price on N/A is Rs.₹136.3 today.
What is the Market Cap of Valiant Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Valiant Laboratories Ltd is ₹592.22 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Valiant Laboratories Ltd?
The PE and PB ratios of Valiant Laboratories Ltd is 0 and 2.44 as of 22 Jul ‘24
What is the 52 Week High and Low of Valiant Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Valiant Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Valiant Laboratories Ltd is ₹128.7 and ₹226.95 as of 22 Jul ‘24
What is the CAGR of Valiant Laboratories Ltd?
Valiant Laboratories Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -21.18%, 6 Month at -34.67%, 3 Month at -16.14% and 1 Month at -10.18%.
What is the shareholding pattern of Valiant Laboratories Ltd?
The shareholding pattern of Valiant Laboratories Ltd is as follows:
Promoters - 74.94 %
Institutions - 1.89 %
Public - 23.17 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
